|

Neoantigen Dendritic Cell Vaccine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Centre, Singapore1

Indications

  • Liver Disease1
  • Liver Metastases1
  • Colorectal Carcinoma1
  • Hepatocellular Cancer1
  • Liver Cancer1

Other1 trial

Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.